These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9360686)

  • 1. Prognosis for patients with sclerosing encapsulating peritonitis following CAPD.
    Yokota S; Kumano K; Sakai T
    Adv Perit Dial; 1997; 13():221-3. PubMed ID: 9360686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis.
    Klimopoulos S; Katsoulis IE; Margellos V; Nikolopoulou N
    J R Coll Surg Edinb; 2002 Apr; 47(2):485-90. PubMed ID: 12018692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerosing encapsulating peritonitis: a case series from a single U.K. center during a 10-year period.
    Jenkins SB; Leng BL; Shortland JR; Brown PW; Wilkie ME
    Adv Perit Dial; 2001; 17():191- 5. PubMed ID: 11510272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group.
    Nomoto Y; Kawaguchi Y; Kubo H; Hirano H; Sakai S; Kurokawa K
    Am J Kidney Dis; 1996 Sep; 28(3):420-7. PubMed ID: 8804242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment for sclerosing encapsulating peritonitis.
    Kawanishi H; Harada Y; Sakikubo E; Moriishi M; Nagai T; Tsuchiya S
    Adv Perit Dial; 2000; 16():252-6. PubMed ID: 11045305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of cases with massive ascites accumulation after discontinuation of CAPD: an attempt to establish the concept of the pre-sclerosing encapsulating peritonitis(pre-SEP) state].
    Kasai K; Terawaki H; Otsuka Y; Hamaguchi A; Kondo M; Tanno Y; Hara Y; Ichinose M; Kawaguchi Y; Hosoya T
    Nihon Jinzo Gakkai Shi; 2000 May; 42(4):346-52. PubMed ID: 10897594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea.
    Kim BS; Choi HY; Ryu DR; Yoo TH; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
    Yonsei Med J; 2005 Feb; 46(1):104-11. PubMed ID: 15744812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems in the surgical management of sclerosing encapsulating peritonitis.
    Assalia A; Schein M; Hashmonai M
    Isr J Med Sci; 1993 Nov; 29(11):686-8. PubMed ID: 8270396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Encapsulating sclerosing peritonitis: report of 2 cases].
    Staniscia G; Maccarone M; Tidona V; Sardellone A; De Nicola E; Viola D
    Ann Ital Chir; 2003; 74(3):343-7. PubMed ID: 14677292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.
    Hauglustaine D; van Meerbeek J; Monballyu J; Goddeeris P; Lauwerijns J; Michielsen P
    Clin Nephrol; 1984 Sep; 22(3):158-62. PubMed ID: 6488597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for encapsulating peritoneal sclerosis based on progressive stage.
    Kawanishi H; Harada Y; Noriyuki T; Kawai T; Takahashi S; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2001; 17():200-4. PubMed ID: 11510276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis.
    Tan FL; Loh D; Prabhakaran K
    J Pediatr Surg; 2005 May; 40(5):e21-3. PubMed ID: 15937801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implementing HPN in an SEP case following long-term CAPD].
    Kaneko K; Hidaka K; Koyama K; Ishii J; Yokota S; Ouchi T
    Gan To Kagaku Ryoho; 1998 Dec; 25 Suppl 4():589-94. PubMed ID: 9884646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sclerosing encapsulating peritonitis: a latent threat. Changes of posture in surgery treatment].
    Herrero JC; Molina A; Lentisco C; García C; Ortiz M; Mon C; Ortega O; Rodríguez I; Oliet A; Vigil A; Gallar P
    Nefrologia; 2007; 27(6):729-36. PubMed ID: 18336103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea.
    Lee HY; Kim BS; Choi HY; Park HC; Kang SW; Choi KH; Ha SK; Han DS
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S33-9. PubMed ID: 15012689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation.
    Moustafellos P; Hadjianastassiou V; Roy D; Velzeboer NE; Maniakyn N; Vaidya A; Friend PJ
    Transplant Proc; 2006 Nov; 38(9):2913-4. PubMed ID: 17112862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan.
    Nakamoto H; Kawaguchi Y; Suzuki H
    Adv Perit Dial; 2002; 18():119-23. PubMed ID: 12402602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerosing peritonitis complicating continuous ambulatory peritoneal dialysis with the use of chlorhexidine in alcohol.
    Lo WK; Chan KT; Leung AC; Pang SW; Tse CY
    Adv Perit Dial; 1990; 6():79-84. PubMed ID: 1982846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.